| Pharmaceutical active ingredients: |
| Naltrexone Hydrochloride |
| Available forms, composition and doses of Nalerona: |
| Tablets; Oral; Naltrexone Hydrochloride 50 mg |
| Nalerona medical category: |
| Human:AntidotesDetoxifying agents and drugs used in substance dependenceOpioid receptor antagonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N07BB04 - Naltrexone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Silesia Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Naldecon Syrup | Acetaminophen; Ammonium Chloride; Chlorpheniramine Maleate; Menthol; Phenylpropanolamine Hydrochloride; Sodium Citrate | Meridian Medicare |
| Naldecon Tablets | Acetaminophen; Carbinoxamine Maleate; Phenylephrine Hydrochloride | Bristol-Myers Squibb |
| Naldecon Tablets | Acetaminophen; Caffeine Anhydrous; Chlorpheniramine Maleate; Pseudoephedrine Hydrochloride | Meridian Medicare |
| Naldegesic | Acetaminophen | Unidentified Pharmaceutical Company |
| Naldelate DX Adult | Dextromethorphan Hydrobromide; Guaifenesin; Phenylpropanolamine Hydrochloride | Alpharma |
| Naletal | Cilostazol | Guardian Pharmatama |
| Nalex | Guaifenesin; Pseudoephedrine Hydrochloride | Blansett Pharmacal |
| Nalex DH | Hydrocodone Tartrate; Phenylephrine Hydrochloride | Blansett Pharmacal |
| Nalex Expectorant | Guaifenesin; Hydrocodone Tartrate; Pseudoephedrine Hydrochloride | Blansett Pharmacal |
| Nalex-A | Chlorpheniramine Maleate; Phenylephrine Hydrochloride; Phenyltoloxamine Citrate | Blansett Pharmacal |